| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.033 | 0.4 |